Home / Resource Library / R-CHOP With Added Genetic Subtype-Based Targeted Therapy Improves CR Rates in Newly Diagnosed DLBCLR-CHOP With Added Genetic Subtype-Based Targeted Therapy Improves CR Rates in Newly Diagnosed DLBCL ICML 2021: